Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.9 |
mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.0069 | 0.9 |
mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |
mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |